Revenue increased by 9.5% to $291.9 million for the three months ended March 31, 2026, compared to $266.6 million for the three months ended March 29, 2025. Net income decreased significantly by 47.3% to $33.8 million in Q1 2026 from $64.1 million in Q1 2025. Diluted earnings per share fell by 48.5% to $0.67 in Q1 2026 from $1.30 in Q1 2025. Gross profit as a percentage of revenue decreased to 50.1% in Q1 2026 from 53.7% in Q1 2025, primarily due to higher restructuring expenses and inventory step-up amortization from the Semilab USA acquisition. Operating expenses rose substantially by 40.9% to $112.9 million in Q1 2026 from $80.1 million in Q1 2025, driven by increased research and development, sales and marketing, general and administrative, amortization, and restructuring costs. Net cash provided by operating activities decreased significantly to $26.3 million in Q1 2026 from $92.0 million in Q1 2025. Cash, cash equivalents, and marketable securities increased to $654.2 million at March 31, 2026, from $639.6 million at January 3, 2026. The company announced a subsequent event to acquire 27% of Rigaku Holdings Corporation for approximately $710 million, expected to close in the second half of 2026. A $500 million senior secured 364-day bridge term loan credit facility from Goldman Sachs Bank USA was secured to help finance the Rigaku acquisition.